In a patient undergoing mechanical ventilation for at least 3 days, does a 3-day course of inhaled amikacin reduce the incidence of ventilator-associated pneumonia compared to placebo, and is it safe?

Saved in:
Bibliographic Details
Published in:La revue de medecine interne 2024-01, Vol.45 (1), p.55-56
Main Authors: Lanthier, L, Mayette, M, Plourde, M-É, Cauchon, M
Format: Article
Language:eng ; fre
Subjects:
Amikacin - therapeutic use
Anti-Bacterial Agents - therapeutic use
Humans
Incidence
Intensive Care Units
Pneumonia, Ventilator-Associated - drug therapy
Pneumonia, Ventilator-Associated - epidemiology
Pneumonia, Ventilator-Associated - prevention & control
Respiration, Artificial - adverse effects
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1768-3122
DOI:10.1016/j.revmed.2023.12.002